BMRN Insider Trading Activity and SEC Form 4 Filings
Trump's trades in BMRN
From his financial disclosures
$1K+
1 purchase
-
0 sales
Purchase
Apr 17, 2026
Reported 75d later
$1K - $15K
Many orders in these accounts are placed by the account manager.
BMRN insider trading summary
Over the past 12 months, insiders at Biomarin Pharmaceutical Inc (BMRN) reported 3 sales worth $2.3M by 3 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.3M.
Latest BMRN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 2, 2026 | George Eric Davis | EVP, Chief Legal Officer | Sell | $1.2M (17,557 @ $66.28) |
| May 7, 2026 | Gregory R Friberg | EVP, Chief R&D Officer | Sell | $177K (3,281 @ $53.85) |
| Mar 11, 2026 | Charles Greg Guyer | EVP, Chief Technical Officer | Sell | $997K (16,486 @ $60.46) |
| May 20, 2025 | Erin Burkhart | GVP, Chief Accounting Officer | Sell | $106K (1,786 @ $59.31) |
| May 2, 2025 | Cristin Hubbard | EVP, Chief Commercial Officer | Sell | $18K (273 @ $64.92) |
| Mar 19, 2025 | Erin Burkhart | GVP, Chief Accounting Officer | Sell | $93K (1,295 @ $71.52) |
| Mar 6, 2025 | Charles Greg Guyer | EVP, Chief Technical Officer | Sell | $501K (7,034 @ $71.28) |
| Feb 24, 2025 | Erin Burkhart | GVP, Chief Accounting Officer | Sell | $92K (1,344 @ $68.38) |
| Nov 12, 2024 | Charles Greg Guyer | EVP, Chief Technical Officer | Sell | $350K (5,278 @ $66.37) |
| Aug 13, 2024 | Erin Burkhart | GVP, Chief Accounting Officer | Sell | $64K (714 @ $90.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.